----

|   | [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|-----|-----------------------------------------------------------------------------------------|

|   | [  ] | TRANSITION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|-----------|----------------------------------------------------------------------------------------------------|

| MARYLAND                                 | 27-3008946         |
|------------------------------------------|--------------------|
| (State or Other Jurisdiction of          | (I.R.S. Employer   |
| Incorporation or Organization)           | Identification No) |
|                                     |               |
| 150 Almaden Boulevard, Suite 1250        |               |
| San Jose, California                     | 95113              |
| (Address of Principal Executive Offices) | (Zip Code)         |
|   | [   ] | Large Accelerated Filer | [X]             | Accelerated Filer         |
|--------|-----------------|-------------------------|-----------------|---------------------------|
|   | [   ] | Non-accelerated Filer   | [   ] | Smaller Reporting Company |
| Class                                    | Outstanding at July 31, 2017 |
|------------------------------------------|------------------------------|
| Common Stock, $0.001 par value per share | 7,430,697                    |

----

----

| PART I.    | FINANCIAL INFORMATION                                                                                                                                                                                                                                                                                                                | 2  |
|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----|
| Item 1.    | Financial Statements                                                                                                                                                                                                                                                                                                                 | 2  |
|       | Consolidated Statements of Assets and Liabilities as of June 30, 2017 (Unaudited) and December 31, 2016                                                                                                                                                                                                                              | 3  |
|       | Consolidated Statements of Operations (Unaudited) for the Three Months Ended June 30, 2017, and June 30, 2016 and for the Six Months Ended June 30, 2017, and June 30, 2017                                                                                                                                                          | 4  |
|       | Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2017 (Unaudited) and the Six Months Ended June 30, 2016 (Unaudited)                                                                                                                                                                                          | 5  |
|       | Consolidated Statements of Changes in Net Assets for the Six Months Ended June 30, 2017 (Unaudited) and the Year Ended December 31, 2016                                                                                                                                                                                             | 6  |
|       | Selected Per Share Data and Ratios for the Six Months Ended June 30, 2017 (Unaudited) (Consolidated), for the Year Ended December 31, 2016 (Consolidated), for the Year Ended December 31, 2015 (Consolidated), for the Year Ended December 31, 2014, for the Year Ended December 31, 2013, and for the Year Ended December 31, 2012 | 7  |
|       | Consolidated Schedule of Investments (Unaudited) as of June 30, 2017                                                                                                                                                                                                                                                                 | 8  |
|       | Consolidated Notes To Financial Statements (Unaudited)                                                                                                                                                                                                                                                                               | 13 |
| Item 2.    | Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                                                                                                                                                                                                          | 28 |
| Item 3.    | Quantitative and Qualitative Disclosures About Market Risk                                                                                                                                                                                                                                                                           | 36 |
| Item 4.    | Controls and Procedures                                                                                                                                                                                                                                                                                                              | 38 |
| PART II.   | OTHER INFORMATION                                                                                                                                                                                                                                                                                                                    | 39 |
| Item 1.    | Legal Proceedings                                                                                                                                                                                                                                                                                                                    | 40 |
| Item 1A.   | Risk Factors                                                                                                                                                                                                                                                                                                                         | 40 |
| Item 2.    | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                                                                                          | 40 |
| Item 3.    | Defaults Upon Senior Securities                                                                                                                                                                                                                                                                                                      | 40 |
| Item 4.    | Mine Safety Disclosures                                                                                                                                                                                                                                                                                                              | 40 |
| Item 5.    | Other Information                                                                                                                                                                                                                                                                                                                    | 40 |
| Item 6.    | Exhibits                                                                                                                                                                                                                                                                                                                             | 40 |
| SIGNATURES |                                                                                                                                                                                                                                                                                                                                 | 41 |

----

----

----

|                                                                   |   | AS OFJUNE 30, 2017(UNAUDITED) |        |   | AS OFDECEMBER 31, 2016 |   |
|------------------------------------------------------------------------|--------|-------------------------------|-------------|--------|------------------------|--------|
| ASSETS                                                                 |   |                          |        |   |                   |   |
| Investment securities:                                                 |   |                          |        |   |                   |   |
| Unaffiliated investments at acquisition cost                           |   | $                             | 40,762,524  |   |                   | $      | 66,336,448 |   |
| Affiliated investments at acquisition cost                             |   |                          | 23,561,205  |   |                   |   | 11,898,906 |   |
| Controlled investments at acquisition cost                             |   |                          | 103,960,410 |   |                   |   | 96,551,795 |   |
| Total acquisition cost                                                 |   | $                             | 168,284,139 |   |                   | $      | 174,787,149 |   |
| Unaffiliated investments at market value                               |   | $                             | 30,762,722  |   |                   | $      | 51,202,592 |   |
| Affiliated investments at market value                                 |   |                          | 19,056,057  |   |                   |   | 10,410,045 |   |
| Controlled investments at market value                                 |   |                          | 82,893,779  |   |                   |   | 85,918,212 |   |
| Total market value * (Note 6)                                          |   |                          | 132,712,558 |   |                   |   | 147,530,849 |   |
| Cash                                                                   |   |                          | 6,821,445   |   |                   |   | 1,934,247 |   |
| Receivable from dividends and interest                                 |   |                          | 1,169,592   |   |                   |   | 820,824 |   |
| Other assets                                                           |   |                          | 24,669      |   |                   |   | 28,513 |   |
| Total Assets                                                           |   |                          | 140,728,264 |   |                   |   | 150,314,433 |   |
| LIABILITIES                                                            |   |                          |        |   |                   |   |   |   |
| Payable for securities purchased                                       |   |                          | 90,066      |   |                   |   | 395,532 |   |
| Payable to affiliates (Note 4)                                         |   |                          | 749,588     |   |                   |   | 796,533 |   |
| Consulting fee payable                                                 |   |                          | 25,000      |   |                   |   | 27,250 |   |
| Accrued expenses and other payables                                    |   |                          | 118,509     |   |                   |   | 182,727 |   |
| Total Liabilities                                                      |   |                          | 983,163     |   |                   |   | 1,402,042 |   |
| NET ASSETS                                                             |   | $                             | 139,745,101 |   |                   | $      | 148,912,391 |   |
| Net Assets consist of:                                                 |   |                          |        |   |                   |   |   |   |
| Common Stock, par value $0.001 per share 100,000,000 shares authorized |   | $                             | 7,431       |   |                   | $      | 7,431 |   |
| Paid-in-capital                                                        |   |                          | 184,698,313 |   |                   |   | 184,698,313 |   |
| Accumulated net investment loss                                        |   |                          | (1,412,801  | )      |                   |   | — |   |
| Accumulated net realized loss from security transactions               |   |                          | (7,976,261  | )      |                   |   | (8,537,053 | ) |
| Net unrealized depreciation on investments and warrants transactions   |   |                          | (35,571,581 | )      |                   |   | (27,256,300 | ) |
| NET ASSETS                                                             |   | $                             | 139,745,101 |   |                   | $      | 148,912,391 |   |
| Shares of Common Stock outstanding                                     |   |                          | 7,430,697   |   |                   |   | 7,430,697 |   |
| Net asset value per share (Note 2)                                     |   | $                             | 18.81       |   |                   | $      | 20.04 |   |

| * | Includes warrants whose primary risk exposure is equity contracts. |
|---|--------------------------------------------------------------------|

----

|                                                                         |   | FOR THE THREE MONTHS ENDED |        |   | FOR THE SIX MONTHS ENDED |   |
|------------------------------------------------------------------------------|--------|----------------------------|-------------|--------|--------------------------|--------|
|                                                                         |   | JUNE 30, 2017(UNAUDITED)   |        |   | JUNE 30, 2016(UNAUDITED) |   |   | JUNE 30, 2017(UNAUDITED) |   |   | JUNE 30, 2016(UNAUDITED) |   |
| INVESTMENT INCOME                                                            |   |                       |        |   |                     |   |   |   |   |   |   |   |
| Unaffiliated dividends                                                       |   | $                          | —     |   |                     | $      | 4,342 |   |   | $ | — |   |   | $ | 4,342 |   |
| Unaffiliated interest                                                        |   |                       | 22,557      |   |                     |   | 11,231 |   |   |   | 29,265 |   |   |   | 11,467 |   |
| Affiliated/Controlled interest                                               |   |                       | 326,739     |   |                     |   | 201,307 |   |   |   | 580,829 |   |   |   | 360,986 |   |
| TOTAL INVESTMENT INCOME                                                      |   |                       | 349,296     |   |                     |   | 216,880 |   |   |   | 610,094 |   |   |   | 376,795 |   |
| EXPENSES                                                                     |   |                       |        |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Investment advisory fees (Note 4)                                            |   |                       | 726,250     |   |                     |   | 836,291 |   |   |   | 1,467,402 |   |   |   | 1,697,112 |   |
| Administration fees                                                          |   |                       | 47,484      |   |                     |   | 38,378 |   |   |   | 93,651 |   |   |   | 75,255 |   |
| Custody fees                                                                 |   |                       | 7,848       |   |                     |   | 3,539 |   |   |   | 10,622 |   |   |   | 7,077 |   |
| Transfer agent fees                                                          |   |                       | 7,506       |   |                     |   | 6,244 |   |   |   | 14,701 |   |   |   | 13,419 |   |
| Registration and filing fees                                                 |   |                       | 5,759       |   |                     |   | 5,744 |   |   |   | 11,455 |   |   |   | 11,487 |   |
| Professional fees                                                            |   |                       | 129,162     |   |                     |   | 81,717 |   |   |   | 245,303 |   |   |   | 262,405 |   |
| Printing fees                                                                |   |                       | 15,780      |   |                     |   | 18,939 |   |   |   | 29,916 |   |   |   | 37,917 |   |
| Trustees fees                                                                |   |                       | 25,000      |   |                     |   | 25,000 |   |   |   | 50,000 |   |   |   | 50,000 |   |
| Compliance fees                                                              |   |                       | 26,225      |   |                     |   | 44,335 |   |   |   | 52,609 |   |   |   | 93,785 |   |
| Miscellaneous fees                                                           |   |                       | 23,693      |   |                     |   | 17,142 |   |   |   | 47,236 |   |   |   | 30,799 |   |
| TOTAL NET EXPENSES                                                           |   |                       | 1,014,707   |   |                     |   | 1,077,329 |   |   |   | 2,022,895 |   |   |   | 2,279,256 |   |
|                                                                         |   |                       |        |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| NET INVESTMENT LOSS                                                          |   |                       | (665,411    | )      |                     |   | (860,449 | ) |   |   | (1,412,801 | ) |   |   | (1,902,461 | ) |
| Net Realized and Unrealized Gains (Losses) on Investments:                   |   |                       |        |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Net realized gains (losses) from security transactions Affiliated/Controlled |   |                       | —     |   |                     |   | 864,024 |   |   |   | — |   |   |   | 503,271 |   |
| Non-affiliated and other assets                                              |   |                       | 1,633,244   |   |                     |   | 3,348,667 |   |   |   | 560,792 |   |   |   | 7,024,263 |   |
| Net change in unrealized depreciation on investments                         |   |                       | (10,458,990 | )      |                     |   | (4,600,443 | ) |   |   | (9,115,270 | ) |   |   | (20,825,801 | ) |
| Net change in unrealized appreciation on warrants transactions (1)           |   |                       | 419,326     |   |                     |   | 271,816 |   |   |   | 799,989 |   |   |   | 6,208,244 |   |
| Net Realized and Unrealized Losses on Investments                            |   |                       | (8,406,420  | )      |                     |   | (115,936 | ) |   |   | (7,754,489 | ) |   |   | (7,090,023 | ) |
| Net Decrease In Net Assets Resulting From Operations                         |   | $                          | (9,071,831  | )      |                     | $      | (976,385 | ) |   | $ | (9,167,290 | ) |   | $ | (8,992,484 | ) |
| Net Decrease In Net Assets Per Share Resulting From Operations (2)           |   | $                          | (1.22       | )      |                     | $      | (0.13 | ) |   | $ | (1.23 | ) |   | $ | (1.17 | ) |

| (1) | Primary risk exposure is equity contracts. |
|-----|--------------------------------------------|

| (2) | Per share results are calculated based on weighted average shares outstanding for each period. |
|-----|------------------------------------------------------------------------------------------------|

----

|                                                                                                                                |   | FOR THESIX MONTHS ENDEDJUNE 30, 2017(UNAUDITED) |       |   | FOR THESIX MONTHS ENDEDJUNE 30, 2016(UNAUDITED) |   |
|-------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------|------------|--------|-------------------------------------------------|--------|
| CASH FLOWS FROM OPERATING ACTIVITIES                                                                                                |   |                                            |       |   |                                            |   |
| Net decrease in Net Assets resulting from operations                                                                                |   | $                                               | (9,167,290 | )      |                                            | $      | (8,992,484 | ) |
|                                                                                                                                |   |                                            |       |   |                                            |   |   |   |
| Adjustments to reconcile net decrease in Net Assets derived from operations to net cash provided by (used in) operating activities: |   |                                            |       |   |                                            |   |   |   |
| Purchases of investments                                                                                                            |   |                                            | (8,509,165 | )      |                                            |   | (39,534,269 | ) |
| Proceeds from disposition of investments                                                                                            |   |                                            | 18,918,692 |   |                                            |   | 49,309,176 |   |
| Net purchases from short-term investments                                                                                           |   |                                            | (3,345,725 | )      |                                            |   | (1,381,102 | ) |
| Increase (decrease) in dividends, interest, and reclaims receivable                                                                 |   |                                            | (348,768   | )      |                                            |   | 2,863,020 |   |
| Decrease in restricted cash                                                                                                         |   |                                            | —    |   |                                            |   | 1,000,000 |   |
| Decrease in other assets                                                                                                            |   |                                            | 3,844      |   |                                            |   | 738,153 |   |
| Decrease in payable for investment purchased                                                                                        |   |                                            | (305,466   | )      |                                            |   | — |   |
| Decrease in payable to affiliates                                                                                                   |   |                                            | (46,945    | )      |                                            |   | (59,081 | ) |
| Decrease in accrued expenses and other payables                                                                                     |   |                                            | (66,468    | )      |                                            |   | (111,502 | ) |
| Net realized gain from investments                                                                                                  |   |                                            | (560,792   | )      |                                            |   | (7,527,534 | ) |
| Net unrealized (appreciation) and depreciation from investments, other assets, and warrants transactions                            |   |                                            | 8,315,281  |   |                                            |   | 14,617,557 |   |
| Net cash (used in) provided by operating activities                                                                                 |   |                                            | 4,887,198  |   |                                            |   | 10,921,934 |   |
|                                                                                                                                |   |                                            |       |   |                                            |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES                                                                                                |   |                                            |       |   |                                            |   |   |   |
| Cost of shares repurchased                                                                                                          |   |                                            | —    |   |                                            |   | (1,037,711 | ) |
| Net cash (used in) financing activities                                                                                             |   |                                            | —    |   |                                            |   | (1,037,711 | ) |
|                                                                                                                                |   |                                            |       |   |                                            |   |   |   |
| Net increase in cash                                                                                                                |   |                                            | 4,887,198  |   |                                            |   | 9,884,223 |   |
| Cash - beginning of period                                                                                                          |   |                                            | 1,934,247  |   |                                            |   | 767,286 |   |
| Cash - end of period                                                                                                                |   | $                                               | 6,821,445  |   |                                            | $      | 10,651,509 |   |

----

|                                                                           |   | FOR THE SIX MONTHS ENDED JUNE 30, 2017 (UNAUDITED) |        |   | FOR THE YEAR ENDED DECEMBER 31, 2016 |   |
|--------------------------------------------------------------------------------|--------|----------------------------------------------------|-------------|--------|--------------------------------------|--------|
| FROM OPERATIONS:                                                               |   |                                               |        |   |                                 |   |
| Net investment loss                                                            |   | $                                                  | (1,412,801  | )      |                                 | $      | (3,835,503 | ) |
| Net realized gains (loss) from security transactions and warrants transactions |   |                                               | 560,792     |   |                                 |   | (6,167,339 | ) |
| Net change in unrealized depreciation on investments and warrants transactions |   |                                               | (8,315,281  | )      |                                 |   | (14,658,712 | ) |
| Net decrease in net assets from operations                                     |   |                                               | (9,167,290  | )      |                                 |   | (24,661,554 | ) |
|                                                                           |   |                                               |        |   |                                 |   |   |   |
| FROM CAPITAL SHARE TRANSACTIONS:                                               |   |                                               |        |   |                                 |   |   |   |
| Value of shares repurchased                                                    |   |                                               | —     |   |                                 |   | (2,005,434 | ) |
| Net increase (decrease) in net assets from capital share transactions          |   |                                               | —     |   |                                 |   | (2,005,434 | ) |
| TOTAL DECREASE IN NET ASSETS                                                   |   |                                               | (9,167,290  | )      |                                 |   | (26,666,988 | ) |
|                                                                           |   |                                               |        |   |                                 |   |   |   |
| NET ASSETS:                                                                    |   |                                               |        |   |                                 |   |   |   |
| Beginning of period                                                            |   |                                               | 148,912,391 |   |                                 |   | 175,579,379 |   |
| End of period                                                                  |   | $                                                  | 139,745,101 |   |                                 | $      | 148,912,391 |   |
| Accumulated Net Investment Loss                                                |   | $                                                  | (1,412,801  | )      |                                 | $      | — |   |
|                                                                           |   |                                               |        |   |                                 |   |   |   |
| COMMON STOCK ACTIVITY:                                                         |   |                                               |        |   |                                 |   |   |   |
| Shares repurchased                                                             |   |                                               | —     |   |                                 |   | (272,008 | ) |
| Net decrease in shares outstanding                                             |   |                                               | —     |   |                                 |   | (272,008 | ) |
| Shares outstanding, beginning of period                                        |   |                                               | 7,430,697   |   |                                 |   | 7,702,705 |   |
| Shares outstanding, end of period                                              |   |                                               | 7,430,697   |   |                                 |   | 7,430,697 |   |

----

|                                                                    |   | FOR THE SIX MONTHS ENDED JUNE 30, 2017* (UNAUDITED) |    |   | FOR THE YEAR ENDED DECEMBER 31, 2016* |   |    | FOR THE YEAR ENDED DECEMBER 31, 2015* |   |   | FOR THE YEAR ENDED DECEMBER 31, 2014 |   |   | FOR THE YEAR ENDED DECEMBER 31, 2013 |    |   | FOR THE YEAR ENDED DECEMBER 31, 2012 |   |
|-------------------------------------------------------------------------|--------|-----------------------------------------------------|---------|--------|---------------------------------------|--------|---------|--------------------------------------------|--------|--------|--------------------------------------|--------|--------|--------------------------------------|---------|--------|--------------------------------------|--------|
| Net asset value at beginning of period                                  |   | $                                                   | 20.04   |   |                                  | $      | 22.79   |                                       |   | $      | 24.49                                |   |   | $                                    | 28.32   |   |                                 | $      | 22.90 |   |   | $ | 23.92 |   |
| Income from investment operations:                                      |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Net investment loss                                                     |   |                                                | (0.19   | )      |                                  |   | (0.52   | )                                          |   |   | (0.06                                | )(1)   |   |                                 | (1.26   | )      |                                 |   | (1.42 | ) |   |   | (0.39 | ) |
| Net realized and unrealized gains (losses) on investments               |   |                                                | (1.04   | )      |                                  |   | (2.76   | )                                          |   |   | (1.78                                | )      |   |                                 | 3.04    |   |                                 |   | 7.16 |   |   |   | (1.01 | ) |
| Total from investment operations                                        |   |                                                | (1.23   | )      |                                  |   | (3.28   | )                                          |   |   | (1.84                                | )      |   |                                 | 1.78    |   |                                 |   | 5.74 |   |   |   | (1.40 | ) |
|                                                                    |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Distributions from:                                                     |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Realized capital gains                                                  |   |                                                | — |   |                                  |   | — |                                       |   |   | —                              |   |   |                                 | (5.86   | )      |                                 |   | (0.32 | ) |   |   | — |   |
| Premiums from shares sold in offerings                                  |   |                                                | — |   |                                  |   | — |                                       |   |   | —                              |   |   |                                 | — |   |                                 |   | — | (2)  |   |   | 0.38 |   |
| Anti-dilutive effect from capital share transactions                    |   |                                                | — |   |                                  |   | 0.53    |                                       |   |   | 0.14                                 |   |   |                                 | 0.25    |   |                                 |   | — |   |   |   | — |   |
| Net asset value at end of period                                        |   | $                                                   | 18.81   |   |                                  | $      | 20.04   |                                       |   | $      | 22.79                                |   |   | $                                    | 24.49   |   |                                 | $      | 28.32 |   |   | $ | 22.90 |   |
|                                                                    |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Market value at end of period                                           |   | $                                                   | 8.39    |   |                                  | $      | 7.67    |                                       |   | $      | 8.17                                 |   |   | $                                    | 18.65   |   |                                 | $      | 23.17 |   |   | $ | 17.44 |   |
|                                                                    |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Total return                                                            |   |                                                |    |   |                                  |   |    |                                       |   |   |                                 |   |   |                                 |    |   |                                 |   |   |   |   |   |   |   |
| Based on Net Asset Value                                                |   |                                                | (6.14   | )%(A)  |                                  |   | (12.07  | )%                                         |   |   | (6.94                                | )%     |   |                                 | 12.54   | %      |                                 |   | 25.30 | % |   |   | (4.26 | )% |
| Based on Market Value                                                   |   |                                                | 9.39    | %(A)   |                                  |   | (6.12   | )%                                         |   |   | (56.19                               | )%     |   |                                 | 4.76    | %      |                                 |   | 34.61 | % |   |   | 21.70 | % |
| Net assets at end of period (millions)                                  |   | $                                                   | 139.7   |   |                                  | $      | 148.9   |                                       |   | $      | 175.6                                |   |   | $                                    | 209.7   |   |                                 | $      | 256.9 |   |   | $ | 195.9 |   |
| Ratio of total expenses to average net assets                           |   |                                                | 2.78    | %(B)   |                                  |   | 2.90    | %                                          |   |   | 1.36                                 | %(3)   |   |                                 | 5.29    | %(3)   |                                 |   | 6.52 | %(3) |   |   | 2.56 | % |
| Ratio of total expenses to average net assets, excluding incentive fees |   |                                                | 2.78    | %(B)   |                                  |   | 2.90    | %                                          |   |   | 2.68                                 | %      |   |                                 | 3.12    | %      |                                 |   | 2.67 | % |   |   | 2.56 | % |
| Ratio of net investment loss to average net assets                      |   |                                                | (1.94   | )%(B)  |                                  |   | (2.36   | )%                                         |   |   | (0.24                                | )%     |   |                                 | (4.31   | )%     |                                 |   | (5.96 | )% |   |   | (2.12 | )% |
| Portfolio turnover rate                                                 |   |                                                | 11      | %(A)   |                                  |   | 49      | %                                          |   |   | 22                                   | %      |   |                                 | 95      | %      |                                 |   | 17 | % |   |   | 10 | % |

| * | Consolidated. |
|---|---------------|

| (1) | Calculated using average shares outstanding. |
|-----|----------------------------------------------|

| (2) | Less than $0.005 per share. |
|-----|-----------------------------|

| (3) | Amount includes the incentive fee. For the year ended December 31, 2015, the year ended December 31, 2014, and the year ended December 31, 2013, the ratio of the incentive fee to average net assets was (1.32)%, 2.17%, and 3.85%, respectively. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (A) | Not Annualized. |
|-----|-----------------|

| (B) | Annualized. |
|-----|-------------|

----

| PORTFOLIO COMPANY (% OF NET ASSETS)AND INDUSTRY | TYPE OF INVESTMENT                 |   | SHARES/PAR VALUE ($) |      |   | COST BASIS |   |       | VALUE  |   |
|-------------------------------------------------|------------------------------------|--------|----------------------|-----------|--------|------------|--------|------------|--------|--------|
| ALIPHCOM, INC. (0.9%)                           | Common Stock *(1)                  |   |                 | 2,128,005 |   |       | $      | 10,108,024 |   |   | $ | 1,340,005 |   |
| Consumer Electronics                            |                               |   |                 |      |   |       |   |       |   |   |   |   |   |
| CLOUDERA, INC. (0.2%)                           | Common Stock *(1)                  |   |                 | 20,000    |   |       |   | 580,000    |   |   |   | 272,340 |   |
| Software                                        |                               |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            |                               |   |                 |      |   |       |   |       |   |   |   |   |   |
| EQX CAPITAL, INC. (2.9%)                        | Common Stock *(1)(2)               |   |                 | 100,000   |   |       |   | 20,000     |   |   |   | 44,320 |   |
| Equipment Leasing                               | Preferred Stock - Series A *(1)(2) |   |                 | 4,000,000 |   |       |   | 4,000,000  |   |   |   | 3,975,600 |   |
|                                            |                               |   |                 |      |   |       |   |       |   |   |   | 4,019,920 |   |
| HERA SYSTEMS, INC. (0.8%)                       | Convertible Note (1)(2)            |   |                 |      |   |       |   |       |   |   |   |   |   |
| Aerospace                                       | Matures August 2017                |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 6%                   |   |                 | 30,000    |   |       |   | 30,000     |   |   |   | 13,428 |   |
|                                            | Convertible Note (1)(2)            |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Matures July 2017                  |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 10%                  |   |                 | 200,000   |   |       |   | 200,000    |   |   |   | 433,700 |   |
|                                            | Convertible Note (1)(2)            |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Matures July 2017                  |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 10%                  |   |                 | 65,000    |   |       |   | 65,000     |   |   |   | 140,953 |   |
|                                            | Convertible Promissory Note (1)(2) |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Matures July 2017                  |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 10%                  |   |                 | 70,000    |   |       |   | 70,000     |   |   |   | 151,795 |   |
|                                            | Term Note (1)(2)                   |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Matures July 2017                  |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 10%                  |   |                 | 50,000    |   |       |   | 50,000     |   |   |   | 108,425 |   |
|                                            | Preferred Stock - Series A *(1)(2) |   |                 | 3,642,324 |   |       |   | 2,000,000  |   |   |   | 203,970 |   |
|                                            | Term Note (1)(2)                   |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Matures July 2017                  |   |                 |      |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 3%                   |   |                 | 20,000    |   |       |   | 20,000     |   |   |   | 43,370 |   |
|                                            |                               |   |                 |      |   |       |   |       |   |   |   | 1,095,641 |   |
| HIGHTAIL, INC. (6.2%)                           | Preferred Stock - Series E *(1)(4) |   |                 | 2,268,602 |   |       |   | 9,620,188  |   |   |   | 8,725,270 |   |
| Cloud Computing                                 |                               |   |                 |      |   |       |   |       |   |   |   |   |   |

----

| PORTFOLIO COMPANY (% OF NET ASSETS)AND INDUSTRY | TYPE OF INVESTMENT                         |   | SHARES/PAR VALUE ($) |       |   | COST BASIS |   |       | VALUE  |   |
|-------------------------------------------------|--------------------------------------------|--------|----------------------|------------|--------|------------|--------|------------|--------|--------|
| INTRAOP MEDICAL CORP. (16.5%)                   | Convertible Note (1)(2)                    |   |                 |       |   |       |   |       |   |   |
| Medical Devices                                 | Matures June 2020                          |   |                 |       |   |       |   |       |   |   |
|                                            | Interest Rate 15%                          |   |                 | 1,000,000  |   |       | $      | 1,000,000  |   |   | $ | 1,000,000 |   |
|                                            | Convertible Note (1)(2)                    |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Matures June 2020                          |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 15%                          |   |                 | 1,000,000  |   |       |   | 1,000,000  |   |   |   | 1,000,000 |   |
|                                            | Preferred Stock - Series C *(1)(2)         |   |                 | 26,856,187 |   |       |   | 26,299,938 |   |   |   | 16,018,641 |   |
|                                            | Term Note (1)(2)                           |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Matures February 2020                      |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 8%                           |   |                 | 2,000,000  |   |       |   | 2,000,000  |   |   |   | 2,000,000 |   |
|                                            | Term Note (1)(2)                           |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Matures February 2020                      |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 8%                           |   |                 | 3,000,000  |   |       |   | 3,000,000  |   |   |   | 3,000,000 |   |
|                                            |                                       |   |                 |       |   |       |   |       |   |   |   | 23,018,641 |   |
| NUTANIX, INC. (6.6%)                            | Common Stock *                             |   |                 | 459,772    |   |       |   | 7,376,112  |   |   |   | 9,264,406 |   |
| Networking                                      |                                       |   |                 |       |   |       |   |       |   |   |   |   |   |
| PHUNWARE, INC. (4.9%)                           | Preferred Stock - Series E *(1)(3)         |   |                 | 3,257,328  |   |       |   | 9,999,997  |   |   |   | 6,807,490 |   |
| Mobile Computing                                |                                       |   |                 |       |   |       |   |       |   |   |   |   |   |
| PIVOTAL SYSTEMS CORP. (18.7%)                   | Common Stock Warrants -Class B *(1)(2)     |   |                 | 18,180,475 |   |       |   | 0          |   |   |   | 5,529,228 |   |
| Semiconductor Equipment                         | Preferred Stock Warrants -Series D *(1)(2) |   |                 | 4,158,654  |   |       |   | 0          |   |   |   | 279,877 |   |
|                                            | Preferred Stock - Series A *(1)(2)         |   |                 | 11,914,217 |   |       |   | 6,000,048  |   |   |   | 6,621,922 |   |
|                                            | Preferred Stock - Series B *(1)(2)         |   |                 | 13,065,236 |   |       |   | 6,321,482  |   |   |   | 7,261,658 |   |
|                                            | Preferred Stock - Series C *(1)(2)         |   |                 | 2,291,260  |   |       |   | 2,657,862  |   |   |   | 2,310,048 |   |
|                                            | Preferred Stock - Series D *(1)(2)         |   |                 | 6,237,978  |   |       |   | 3,975,801  |   |   |   | 4,174,455 |   |
|                                            |                                       |   |                 |       |   |       |   |       |   |   |   | 26,177,188 |   |
| QMAT, INC. (10.3%)                              | Convertible Note (1)(2)                    |   |                 |       |   |       |   |       |   |   |   |   |   |
| Advanced Materials                              | Matures March 2019                         |   |                 |       |   |       |   |       |   |   |   |   |   |
|                                            | Interest Rate 8%                           |   |                 | 1,000,000  |   |       |   | 1,000,000  |   |   |   | 1,000,000 |   |
|                                            | Preferred Stock - Series A *(1)(2)         |   |                 | 16,000,240 |   |       |   | 16,000,240 |   |   |   | 10,962,564 |   |
|                                            | Preferred Stock - Series B *(1)(2)         |   |                 | 2,000,000  |   |       |   | 2,000,000  |   |   |   | 2,000,000 |   |
|                                            | Preferred Stock Warrants -Series A *(1)(2) |   |                 | 2,000,000  |   |       |   | 0          |   |   |   | 394,600 |   |
|                                            |                                       |   |                 |       |   |       |   |       |   |   |   | 14,357,164 |   |
| QUICKLOGIC CORP. (1.1%)                         | Common Stock *                             |   |                 | 1,030,000  |   |       |   | 1,578,772  |   |   |   | 1,503,800 |   |
| Semiconductors                                  |                                       |   |                 |       |   |       |   |       |   |   |   |   |   |

----

| PORTFOLIO COMPANY (% OF NET ASSETS)AND INDUSTRY | TYPE OF INVESTMENT                     |   | SHARES/PAR VALUE ($) |       |   | COST BASIS |   |      | VALUE  |   |
|-------------------------------------------------|----------------------------------------|--------|----------------------|------------|--------|------------|--------|-----------|--------|--------|
| REVASUM, INC. (3.7%)                            | Common Stock *(1)(2)                   |   |                 | 10,000     |   |       | $      | 1,000     |   | $      | 11,538 |   |
| Semiconductor Equipment                         | Term Note (1)(2)                       |   |                 |       |   |       |   |      |   |   |   |   |
|                                            | Matures February 2020                  |   |                 |       |   |       |   |      |   |   |   |   |
|                                            | Interest Rate 5%                       |   |                 | 1,000,000  |   |       |   | 1,000,000 |   |   |   | 1,000,000 |   |
|                                            | Preferred Stock - Series A *(1)(2)     |   |                 | 441,998    |   |       |   | 1,999,997 |   |   |   | 1,474,594 |   |
|                                            | Preferred Stock - Series Seed *(1)(2)  |   |                 | 2,200,000  |   |       |   | 2,200,000 |   |   |   | 2,714,800 |   |
|                                            |                                   |   |                 |       |   |       |   |      |   |   |   | 5,200,932 |   |
| ROKU, INC. (1.2%)                               | Common Stock *(1)                      |   |                 | 1,500,000  |   |       |   | 2,312,500 |   |   |   | 1,688,250 |   |
| Consumer Electronics                            |                                   |   |                 |       |   |       |   |      |   |   |   |   |   |
| RORUS, INC. (0.0%)                              | Convertible Note (1)                   |   |                 |       |   |       |   |      |   |   |   |   |   |
| Water Purification                              | Matures June 2021                      |   |                 |       |   |       |   |      |   |   |   |   |   |
|                                            | Interest Rate 2%                       |   |                 | 50,000     |   |       |   | 50,000    |   |   |   | 50,000 |   |
| SILICON GENESIS CORP. (4.2%)                    | Common Stock *(1)(2)                   |   |                 | 921,892    |   |       |   | 169,045   |   |   |   | 15,488 |   |
| Intellectual Property                           | Common Stock Warrants *(1)(2)          |   |                 | 5,000,000  |   |       |   | 0         |   |   |   | 10,000 |   |
|                                            | Common Stock Warrants *(1)(2)          |   |                 | 37,982     |   |       |   | 6,678     |   |   |   | 323 |   |
|                                            | Common Stock Warrants *(1)(2)          |   |                 | 3,000,000  |   |       |   | 0         |   |   |   | 6,000 |   |
|                                            | Preferred Stock -Series 1-C *(1)(2)    |   |                 | 82,914     |   |       |   | 109,518   |   |   |   | 70,460 |   |
|                                            | Preferred Stock -Series 1-D *(1)(2)    |   |                 | 850,830    |   |       |   | 431,901   |   |   |   | 194,500 |   |
|                                            | Preferred Stock -Series 1-E *(1)(2)    |   |                 | 5,704,480  |   |       |   | 2,614,401 |   |   |   | 1,994,286 |   |
|                                            | Preferred Stock -Series 1-F *(1)(2)    |   |                 | 912,453    |   |       |   | 509,785   |   |   |   | 444,365 |   |
|                                            | Preferred Stock -Series 1-G *(1)(2)(5) |   |                 | 48,370,793 |   |       |   | 4,729,221 |   |   |   | 2,886,769 |   |
|                                            | Preferred Stock -Series 1-H *(1)(2)    |   |                 | 837,942    |   |       |   | 963,494   |   |   |   | 229,847 |   |
|                                            |                                   |   |                 |       |   |       |   |      |   |   |   | 5,852,038 |   |
| SUNRUN, INC. (2.7%)                             | Common Stock *                         |   |                 | 524,820    |   |       |   | 4,954,995 |   |   |   | 3,736,718 |   |
| Renewable Energy                                |                                   |   |                 |       |   |       |   |      |   |   |   |   |   |
| SVXR, INC. (0.7%)                               | Preferred Stock - Series A *(1)(3)     |   |                 | 2,013,491  |   |       |   | 1,000,000 |   |   |   | 1,000,000 |   |
| Semiconductor Equipment                         |                                   |   |                 |       |   |       |   |      |   |   |   |   |   |

----

|  PORTFOLIO COMPANY(% OF NET ASSETS) AND INDUSTRY      |  TYPE OF INVESTMENT                                           |   |  SHARES/PAR VALUE ($) |       |   |  COST BASIS |   |      |  VALUE |   |
|------------------------------------------------------------|--------------------------------------------------------------------|--------|----------------------------|------------|--------|------------------|--------|-----------|-------------|--------|
| TELEPATHY INVESTORS, INC. (1.0%)Consumer Electronics  | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 2,000,000  |   |             | $      | 2,000,000 |        |   | $ | 267,400 |   |
|                                                       | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 500,000    |   |             |   | 500,000   |        |   |   | 66,850 |   |
|                                                       | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 300,000    |   |             |   | 300,000   |        |   |   | 40,110 |   |
|                                                       | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 500,000    |   |             |   | 500,000   |        |   |   | 66,850 |   |
|                                                       | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 150,000    |   |             |   | 150,000   |        |   |   | 20,055 |   |
|                                                       | Convertible Note (1)(2)Matures January 2018 Interest Rate 10%      |   |                       | 300,000    |   |             |   | 300,000   |        |   |   | 40,110 |   |
|                                                       | Preferred Stock - Series A *(1)(2)                                 |   |                       | 15,238,000 |   |             |   | 3,999,999 |        |   |   | 882,280 |   |
|                                                       |                                                               |   |                       |       |   |             |   |      |        |   |   | 1,383,655 |   |
| UCT COATINGS, INC. (0.6%)                                  | Common Stock *(1)(3)                                               |   |                       | 1,500,000  |   |             |   | 662,235   |        |   |   | 833,400 |   |
| Advanced Materials                                         | Common Stock Warrants *(1)(3)                                      |   |                       | 2,283      |   |             |   | 67        |        |   |   | 3 |   |
|                                                       |                                                               |   |                       |       |   |             |   |      |        |   |   | 833,403 |   |
| VUFINE, INC. (1.3%)Consumer Electronics                    | Common Stock *(1)(2)                                               |   |                       | 750,000    |   |             |   | 15,000    |        |   |   | 600 |   |
|                                                       | Convertible Note (1)(2)Matures February 2018 Interest Rate 6%      |   |                       | 500,000    |   |             |   | 500,000   |        |   |   | 500,000 |   |
|                                                       | Convertible Note (1)(2)Matures September 2017 Interest Rate 6%     |   |                       | 1,000,000  |   |             |   | 1,000,000 |        |   |   | 1,000,000 |   |
|                                                       | Preferred Stock - Series A *(1)(2)                                 |   |                       | 22,500,000 |   |             |   | 2,250,000 |        |   |   | 288,000 |   |
|                                                       |                                                               |   |                       |       |   |             |   |      |        |   |   | 1,788,600 |   |
| WRIGHTSPEED, INC. (7.5%)                                   | Preferred Stock - Series C *(1)(3)(4)                              |   |                       | 2,267,659  |   |             |   | 6,864,023 |        |   |   | 5,819,040 |   |
| Automotive                                                 | Preferred Stock - Series D *(1)(3)                                 |   |                       | 1,100,978  |   |             |   | 3,375,887 |        |   |   | 3,220,691 |   |
|                                                       | Preferred Stock - Series E *(1)(3)                                 |   |                       | 450,814    |   |             |   | 1,658,996 |        |   |   | 1,375,433 |   |
|                                                       |                                                               |   |                       |       |   |             |   |      |        |   |   | 10,415,164 |   |
| INVESTMENT COMPANY (3.0%)                                  | Fidelity Investments Money Market Treasury Portfolio - Class I (6) |   |                       | 4,181,933  |   |             |   | 4,181,933 |        |   |   | 4,181,933 |    |

| TOTAL INVESTMENTS(Cost $168,284,139) —95.0% |   | $      | 132,712,558 |   |
|---------------------------------------------------|--------|--------|-------------|--------|
| OTHER ASSETS IN EXCESS OFLIABILITIES — 5.0% |   |   | 7,032,543   |   |
| NET ASSETS — 100.0%                         |   | $      | 139,745,101 |   |

----

| * | Non-income producing security. |
|---|--------------------------------|

| (1) | Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). |
|-----|---------------------------------------------------------------------------------------------------------------------------------|

| (2) | Controlled investments. |
|-----|-------------------------|

| (3) | Affiliated issuer. |
|-----|--------------------|

| (4) | A portion represents position held in Firsthand Holdings, Ltd. (See Note 1). |
|-----|------------------------------------------------------------------------------|

| (5) | A portion represents position held in Firsthand Development, Ltd. (See Note 1). |
|-----|---------------------------------------------------------------------------------|

| (6) | The Fidelity Investments Money Market Portfolio invests primarily in U.S. Treasury securities. |
|-----|------------------------------------------------------------------------------------------------|

----

----

----

|                                  | Purchased Options (Contracts) | Warrants (Shares) | Written Options (Contracts) |
|---------------------------------------|-------------------------------|-------------------|-----------------------------|
| Firsthand Technology Value Fund, Inc. | —                       | 32,379,394        | —                     |

----

|  | (1) | each quarter the valuation process begins with each portfolio company or investment being initially valued by the Valuation Committee of the Advisor (as defined below) (the “Adviser Valuation Committee”) or the independent valuation firm; |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the Valuation Committee of the Board on a quarterly basis reviews the preliminary valuation of the Adviser Valuation Committee and that of the independent valuation firms and makes the fair value determination, in good faith, based on the valuation recommendations of the Adviser Valuation Committee and the independent valuation firms; and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | at each quarterly Board meeting, the Board considers the valuations recommended by the Adviser Valuation Committee and the independent valuation firms that were previously submitted to the Valuation Committee of the Board and ratifies the fair value determinations made by the Valuation Committee of the Board. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

|  | - | Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.  For example, the market approach often uses market multiples derived from a set of comparables.  Multiples might lie in ranges with a different multiple for each comparable.  The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative). |
|--|---|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | - | Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted).  The measurement is based on the value indicated by current market expectations about those future amounts.  Those valuation techniques include present value techniques and the multi-period excess earnings method, which is used to measure the fair value of certain assets. |
|--|---|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | - | Asset-Based Approach (A): The asset-based approach examines the value of a company’s assets net of its liabilities to derive a value for the equity holders. |
|--|---|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Level 1 - | Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement.                                                                                                                                                                                                                                                          |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      |                                                                                                                                                                                                                                                                                                                                                                                                           |
| Level 2 - | Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.  These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments in an active or inactive market, interest rates, prepayment speeds, credit risks, yield curves, default rates, and similar data. |
|      |                                                                                                                                                                                                                                                                                                                                                                                                           |
| Level 3 - | Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Company’s own assumptions about the assumptions a market participant would use in valuing the asset or liability based on the best information available.                                                                                                                   |

----

|                     |   | LEVEL 1 QUOTED  PRICES |       |   | LEVEL 2 OTHER  SIGNIFICANT OBSERVABLE INPUTS |   |    | LEVEL 3 SIGNIFICANT  UNOBSERVABLE INPUTS |   |
|--------------------------|--------|------------------------|------------|--------|----------------------------------------------|--------|---------|------------------------------------------|--------|
| Assets                   |   |                   |       |   |                                         |   |    |                                     |   |
| Common Stocks            |   |                   |       |   |                                         |   |    |                                     |   |
| Advanced Materials       |   | $                      | —    |   |                                         | $      | — |                                     |   | $ | 833,400 |   |
| Consumer Electronics     |   |                   | —    |   |                                         |   | — |                                     |   |   | 3,028,855 |   |
| Equipment Leasing        |   |                   | —    |   |                                         |   | — |                                     |   |   | 44,320 |   |
| Intellectual Property    |   |                   | —    |   |                                         |   | — |                                     |   |   | 15,488 |   |
| Networking               |   |                   | 9,264,406  |   |                                         |   | — |                                     |   |   | — |   |
| Renewable Energy         |   |                   | 3,736,718  |   |                                         |   | — |                                     |   |   | — |   |
| Semiconductor            |   |                   | 1,503,800  |   |                                         |   | — |                                     |   |   | — |   |
| Semiconductors Equipment |   |                   | —    |   |                                         |   | — |                                     |   |   | 11,538 |   |
| Software                 |   |                   | —    |   |                                         |   | — |                                     |   |   | 272,340 |   |
| Total Common Stocks      |   |                   | 14,504,924 |   |                                         |   | — |                                     |   |   | 4,205,941 |   |
| Preferred Stocks         |   |                   |       |   |                                         |   |    |                                     |   |   |   |   |
| Advanced Materials       |   |                   | —    |   |                                         |   | — |                                     |   |   | 12,962,564 |   |
| Aerospace                |   |                   | —    |   |                                         |   | — |                                     |   |   | 203,970 |   |
| Automotive               |   |                   | —    |   |                                         |   | — |                                     |   |   | 10,415,164 |   |
| Cloud Computing          |   |                   | —    |   |                                         |   | — |                                     |   |   | 8,725,270 |   |
| Consumer Electronics     |   |                   | —    |   |                                         |   | — |                                     |   |   | 1,170,280 |   |
| Equipment Leasing        |   |                   | —    |   |                                         |   | — |                                     |   |   | 3,975,600 |   |
| Intellectual Property    |   |                   | —    |   |                                         |   | — |                                     |   |   | 5,820,227 |   |
| Medical Devices          |   |                   | —    |   |                                         |   | — |                                     |   |   | 16,018,641 |   |
| Mobile Computing         |   |                   | —    |   |                                         |   | — |                                     |   |   | 6,807,490 |   |
| Semiconductor Equipment  |   |                   | —    |   |                                         |   | — |                                     |   |   | 25,557,477 |   |
| Total Preferred Stocks   |   |                   | —    |   |                                         |   | — |                                     |   |   | 91,656,683 |   |
| Asset Derivatives *      |   |                   |       |   |                                         |   |    |                                     |   |   |   |   |
| Equity Contracts         |   |                   | —    |   |                                         |   | — |                                     |   |   | 6,220,031 |   |
| Total Asset Derivatives  |   |                   | —    |   |                                         |   | — |                                     |   |   | 6,220,031 |   |
| Convertible Notes        |   |                   |       |   |                                         |   |    |                                     |   |   |   |   |
| Advanced Materials       |   |                   | —    |   |                                         |   | — |                                     |   |   | 1,000,000 |   |
| Aerospace                |   |                   | —    |   |                                         |   | — |                                     |   |   | 891,671 |   |
| Consumer Electronics     |   |                   | —    |   |                                         |   | — |                                     |   |   | 2,001,375 |   |
| Medical Devices          |   |                   | —    |   |                                         |   | — |                                     |   |   | 7,000,000 |   |
| Semiconductor Equipment  |   |                   | —    |   |                                         |   | — |                                     |   |   | 1,000,000 |   |
| Water Purification       |   |                   | —    |   |                                         |   | — |                                     |   |   | 50,000 |   |
| Total Convertible Notes  |   |                   | —    |   |                                         |   | — |                                     |   |   | 11,943,046 |   |
| Mutual Funds             |   |                   | 4,181,933  |   |                                         |   | — |                                     |   |   | — |   |
| Total                    |   | $                      | 18,686,857 |   |                                         | $      | — |                                     |   | $ | 114,025,701 |   |

| * | Asset derivatives include warrants. |
|---|-------------------------------------|

----

| INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS  (LEVEL 3) |   | BALANCE AS OF 12/31/16 |       |   | NET PURCHASES |   |      | NET SALES |   |   | NET REALIZED GAINS / (LOSSES) |   |   | NET UNREALIZED APPRECIATION (DEPRECIATION)(1) |      |   | TRANSFERS IN (OUT) OF LEVEL 3 |   |       | BALANCE AS OF 6/30/17 |   |
|----------------------------------------------------------------------------|--------|------------------------|------------|--------|---------------|--------|-----------|-----------|--------|--------|-------------------------------|--------|--------|-----------------------------------------------|-----------|--------|-------------------------------|--------|------------|-----------------------|--------|
| Common Stocks                                                              |   |                   |       |   |          |   |      |      |   |   |                          |   |   |                                          |      |   |                          |   |       |                  |   |
| Advanced Materials                                                         |   | $                      | 394,200    |   |          | $      | —   |      |   | $      | —                       |   |   | $                                             | —   |   |                          | $      | 439,200    |                  |   | $ | — |   |   | $ | 833,400 |   |
| Consumer Electronics                                                       |   |                   | 3,037,441  |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (8,586     | )                     |   |   | — |   |   |   | 3,028,855 |   |
| Equipment Leasing                                                          |   |                   | 44,430     |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (110       | )                     |   |   | — |   |   |   | 44,320 |   |
| Intellectual Property                                                      |   |                   | 14,750     |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 738        |                  |   |   | — |   |   |   | 15,488 |   |
| Networking                                                                 |   |                   | 10,990,390 |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (1,725,984 | )                     |   |   | (9,264,406 | ) |   |   | — |   |
| Semiconductor Equipment                                                    |   |                   | 7,524      |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 4,014      |                  |   |   | — |   |   |   | 11,538 |   |
| Software                                                                   |   |                   | 245,466    |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 26,874     |                  |   |   | — |   |   |   | 272,340 |   |
| Preferred Stocks                                                           |   |                   |       |   |          |   |      |      |   |   |                          |   |   |                                          |      |   |                          |   |       |                  |   |   |   |   |   |   |   |   |
| Advanced Materials                                                         |   |                   | 12,724,961 |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 237,603    |                  |   |   | — |   |   |   | 12,962,564 |   |
| Advertising Technology                                                     |   |                   | 9,757,918  |   |          |   | —   |      |   |   | (12,355,330                   | )      |   |                                          | 1,015,419 |   |                          |   | 1,581,993  |                  |   |   | — |   |   |   | — |   |
| Aerospace                                                                  |   |                   | 445,456    |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (241,486   | )                     |   |   | — |   |   |   | 203,970 |   |
| Automotive                                                                 |   |                   | 10,410,045 |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 5,119      |                  |   |   | — |   |   |   | 10,415,164 |   |
| Cloud Computing                                                            |   |                   | 8,550,361  |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 174,909    |                  |   |   | — |   |   |   | 8,725,270 |   |
| Consumer Electronics                                                       |   |                   | 3,752,749  |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (2,582,469 | )                     |   |   | — |   |   |   | 1,170,280 |   |
| Equipment Leasing                                                          |   |                   | 3,975,600  |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | —    |                  |   |   | — |   |   |   | 3,975,600 |   |
| Intellectual Property                                                      |   |                   | 6,137,917  |   |          |   | —   |      |   |   | (455,231                      | )      |   |                                          | —   |   |                          |   | 137,541    |                  |   |   | — |   |   |   | 5,820,227 |   |
| Medical Devices                                                            |   |                   | 24,511,642 |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (8,493,001 | )                     |   |   | — |   |   |   | 16,018,641 |   |
| Mobile Computing                                                           |   |                   | 7,365,796  |   |          |   | —   |      |   |   | —                       |   |   |                                          | —   |   |                          |   | (558,306   | )                     |   |   | — |   |   |   | 6,807,490 |   |
| Semiconductor Equipment                                                    |   |                   | 21,883,997 |   |          |   | 2,999,997 |      |   |   | —                       |   |   |                                          | —   |   |                          |   | 673,483    |                  |   |   | — |   |   |   | 25,557,477 |   |

----

| INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS  (LEVEL 3) |   | BALANCE AS OF 12/31/16 |        |   | NET PURCHASES/ CONVERSION |   |       | NET SALES/ CONVERSION |   |   | NET REALIZED GAINS / (LOSSES) |   |   | NET UNREALIZED APPRECIATION (DEPRECIATION)(1) |      |   | TRANSFERS IN (OUT) OF LEVEL 3 |   |        | BALANCE AS OF 6/30/17 |   |
|----------------------------------------------------------------------------|--------|------------------------|-------------|--------|---------------------------|--------|------------|-----------------------|--------|--------|-------------------------------|--------|--------|-----------------------------------------------|-----------|--------|-------------------------------|--------|-------------|-----------------------|--------|
| Asset Derivatives                                                          |   |                   |        |   |                      |   |       |                  |   |   |                          |   |   |                                          |      |   |                          |   |        |                  |   |
| Equity Contracts                                                           |   | $                      | 5,420,042   |   |                      | $      | —    |                  |   | $      | —                       |   |   | $                                             | —   |   |                          | $      | 799,989     |                  |   | $ | — |   |   | $ | 6,220,031 |   |
| Convertible Notes                                                          |   |                   |        |   |                      |   |       |                  |   |   |                          |   |   |                                          |      |   |                          |   |        |                  |   |   |   |   |   |   |   |   |
| Advanced Materials                                                         |   |                   | —     |   |                      |   | 1,000,000  |                  |   |   | —                       |   |   |                                          | —   |   |                          |   | —     |                  |   |   | — |   |   |   | 1,000,000 |   |
| Advertising Technology                                                     |   |                   |        |   |                      |   |       |                  |   |   |                          |   |   |                                          |      |   |                          |   |        |                  |   |   |   |   |   |   |   |   |
|                                                                       |   |                   | 559,360     |   |                      |   | —    |                  |   |   | (1,118,720                    | )      |   |                                          | 559,360   |   |                          |   | —     |                  |   |   | — |   |   |   | — |   |
| Aerospace                                                                  |   |                   | 71,208      |   |                      |   | 405,000    |                  |   |   | (41,208                       | )      |   |                                          | —   |   |                          |   | 456,671     |                  |   |   | — |   |   |   | 891,671 |   |
| Automotive                                                                 |   |                   | —     |   |                      |   | 200,000    |                  |   |   | (200,000                      | )      |   |                                          | —   |   |                          |   | —     |                  |   |   | — |   |   |   | — |   |
| Consumer Electronics                                                  |   |                   |        |   |                      |   |       |                  |   |   |                          |   |   |                                          |      |   |                          |   |        |                  |   |   |   |   |   |   |   |   |
|                                                                       |   |                   | 2,913,612   |   |                      |   | 2,800,000  |                  |   |   | (2,000,000                    | )      |   |                                          | —   |   |                          |   | (1,712,237  | )                     |   |   | — |   |   |   | 2,001,375 |   |
| Medical Devices                                                            |   |                   | 4,000,000   |   |                      |   | 3,000,000  |                  |   |   | —                       |   |   |                                          | —   |   |                          |   | —     |                  |   |   | — |   |   |   | 7,000,000 |   |
|                                                                       |   |                   |        |   |                      |   |       |                  |   |   |                          |   |   |                                          |      |   |                          |   |        |                  |   |   |   |   |   |   |   |   |
| Semiconductor Equipment                                                    |   |                   | —     |   |                      |   | 1,000,000  |                  |   |   | —                       |   |   |                                          | —   |   |                          |   | —     |                  |   |   | — |   |   |   | 1,000,000 |   |
| Water Purification                                                         |   |                   | 50,000      |   |                      |   | —    |                  |   |   | —                       |   |   |                                          | —   |   |                          |   | —     |                  |   |   | — |   |   |   | 50,000 |   |
| Total                                                                      |   | $                      | 137,264,865 |   |                      | $      | 11,404,997 |                  |   | $      | (16,170,489                   | )      |   | $                                             | 1,574,779 |   |                          | $      | (10,784,045 | )                     |   | $ | (9,264,406 | ) |   | $ | 114,025,701 |   |

| (1) | The net change in unrealized depreciation from Level 3 instruments held as of June 30, 2017 was $(11,530,713). |
|-----|----------------------------------------------------------------------------------------------------------------|

|                                                   | FAIR VALUE AT 6/30/17 | VALUATION TECHNIQUES                                                       | UNOBSERVABLE INPUTS                                                                           | RANGE  (WEIGHTED AVG.)                      |
|--------------------------------------------------------|-----------------------|----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|---------------------------------------------|
| Direct venture capital investments: Advanced Materials | $15.2M                | Market Comparable CompaniesPrior Transaction Analysis Option Pricing Model | EBITDA MultipleYears to ExpirationVolatilityRisk-Free Rate Discount for Lack of Marketability | 8.7x - 11.5x5 years50.0% - 55.0%1.85% 22.7% |
| Direct venture capital investments: Aerospace          | $1.1M                 | Prior Transaction AnalysisOption Pricing Model                             | Years to ExpirationVolatility Risk-Free Rate                                                  | 5 years60.0% 1.85%                          |
| Direct venture capital investments: Automotive         | $10.4M                | Prior Transaction AnalysisOption Pricing Model                             | Years to ExpirationVolatility Risk-Free Rate                                                  | 3 years55.0% 1.53%                          |

----

| continued                                                   | FAIR VALUE AT 6/30/17 | VALUATION TECHNIQUES                                                                                                                   | UNOBSERVABLE INPUTS                                                                                                                                                                                         | RANGE  (WEIGHTED AVG.)                                                                                                                                           |
|-------------------------------------------------------------|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Direct venture capital investments: Cloud Computing         | $8.7M                 | Market Comparable CompaniesPrior Transaction Analysis Option Pricing Model                                                             | Revenue MultipleYears to ExpirationVolatility Risk-Free Rate                                                                                                                                                | 1.7x - 2.1x2 years40.0% 1.38%                                                                                                                                    |
| Direct venture capital investments: Consumer Electronics    | $6.2M                 | Market Comparable CompaniesPrior Transaction Analysis Probability-Weighted Expected ReturnInvested Capital (Cost) Option Pricing Model | Revenue MultipleIPO Exit Probability Merger & AcquisitionProbabilityGoing Concern ProbabilityYears to ExpirationVolatilityRisk-Free Rate Discount for Lack ofMarketabilityAdjustment for MarketMovement | 0.9x - 1.9x75%25%         25% - 100%1 year - 5 years50.0% - 70.0%1.23% - 1.85%    0.0% - 25.8%    0.0% - 23.6% |
| Direct venture capital investments: Equipment Leasing       | $4.0M                 | Prior Transaction Analysis Option Pricing Model                                                                                        | Years to ExpirationVolatility Risk-Free Rate                                                                                                                                                                | 5 years50.00% 1.85%                                                                                                                                              |
| Direct venture capital investments: Intellectual Property   | $5.8M                 | Prior Transaction AnalysisOption Pricing Model                                                                                         | Years to ExpirationVolatilityRisk-Free Rate Discount for Lack ofMarketabilityAdjustment for MarketMovement                                                                                                  | 5 years55%1.85%    0% - 24.3%     (23.9%)                                                                                               |
| Direct venture capital investments: Medical Devices         | $23.0M                | Market Comparable CompaniesPrior Transaction Analysis Option Pricing Model                                                             | Revenue MultipleYears to ExpirationVolatility Risk-Free Rate                                                                                                                                                | 2.8x - 3.4x4 years50.0% 1.69%                                                                                                                                    |
| Direct venture capital investments: Mobile Computing        | $6.8M                 | Prior Transaction AnalysisOption Pricing Model                                                                                         | Years to ExpirationVolatility Risk-Free Rate                                                                                                                                                                | 2 years60.0% 1.38%                                                                                                                                               |
| Direct venture capital investments: Semiconductor Equipment | $32.4M                | Prior Transaction Analysis Option Pricing Model                                                                                        | Years to ExpirationVolatilityRisk-Free Rate Discount for Lack ofMarketability                                                                                                                               | 2 years - 5 years40.0% - 60.0%1.38% - 1.85%    0.0% - 15.5%                                                                                            |
| Direct venture capital investments: Software                | $0.3M                 | Prior Transaction Analysis                                                                                                             | Discount for Lack ofMarketability                                                                                                                                                                           | 15%                                                                                                                                                              |
| Direct venture capital investments: Water Purification      | $0.1M                 | Prior Transaction Analysis Option Pricing Model                                                                                        | Years to ExpirationVolatility Risk-Free Rate                                                                                                                                                                | 5 years40.0% 1.85%                                                                                                                                               |

----

| Gross unrealized appreciation        |   | $      | 12,956,208  |   |
|--------------------------------------|--------|--------|-------------|--------|
| Gross unrealized depreciation        |   |   | (48,527,789 | )      |
| Net unrealized depreciation          |   | $      | (35,571,581 | )      |
| Federal income tax cost, investments |   | $      | 168,284,139 |   |
| PURCHASES AND SALES                                         |   |   |       |
|-------------------------------------------------------------|--------|--------|------------|
| Purchases of investment securities                          |   | $      | 8,509,165  |   |
| Proceeds from sales and maturities of investment securities |   | $      | 18,918,692 |   |

----

|                                      |   | SHARES/PAR ACTIVITY |       |   |              |   |    |                        |   |   |               |   |   |                 |       |
|-------------------------------------------|--------|---------------------|------------|--------|-------------------|--------|---------|-----------------------------|--------|--------|--------------------|--------|--------|----------------------|------------|
| AFFILIATE/ CONTROLLED INVESTMENT*         |   | BALANCE AT 12/31/16 |       |   | PURCHASES/ MERGER |   |    | SALES/ MATURITY/ EXPIRATION |   |   | BALANCE AT 6/30/17 |   |   | REALIZED GAIN (LOSS) |       |   | INTEREST |   |   | VALUE 6/30/17 |   |   | ACQUISITION COST |   |
| EQX, Inc. Common Stock*                   |   |                | 100,000    |   |              |   | — |                        |   |   | —            |   |   |                 | 100,000    |   |   | $ | — |   |   | $ | — |   |   | $ | 44,320 |   |   | $ | 20,000 |   |
| EQX, Inc. Preferred Stock - Series A*     |   |                | 4,000,000  |   |              |   | — |                        |   |   | —            |   |   |                 | 4,000,000  |   |   |   | — |   |   |   | — |   |   |   | 3,975,600 |   |   |   | 4,000,000 |   |
| Hera Systems, Inc. Term Note*             |   |                | 41,208     |   |              |   | — |                        |   |   | (41,208            | )      |   |                 | —    |   |   |   | — |   |   |   | 70 |   |   |   | — |   |   |   | — |   |
| Hera Systems, Inc. Series A Preferred*    |   |                | 3,642,324  |   |              |   | — |                        |   |   | —            |   |   |                 | 3,642,324  |   |   |   | — |   |   |   | — |   |   |   | 203,970 |   |   |   | 2,000,000 |   |
| Hera Systems, Inc. Term Note*             |   |                | —    |   |              |   | 20,000  |                        |   |   | —            |   |   |                 | 20,000     |   |   |   | — |   |   |   | 282 |   |   |   | 43,370 |   |   |   | 20,000 |   |
| Hera Systems, Inc. Convertible Note*      |   |                | —    |   |              |   | 200,000 |                        |   |   | —            |   |   |                 | 200,000    |   |   |   | — |   |   |   | 8,333 |   |   |   | 433,700 |   |   |   | 200,000 |   |
| Hera Systems, Inc. Convertible Note*      |   |                | 30,000     |   |              |   | — |                        |   |   | —            |   |   |                 | 30,000     |   |   |   | — |   |   |   | 893 |   |   |   | 13,428 |   |   |   | 30,000 |   |
| Hera Systems, Inc. Convertible Note*      |   |                | —    |   |              |   | 65,000  |                        |   |   | —            |   |   |                 | 65,000     |   |   |   | — |   |   |   | 903 |   |   |   | 140,953 |   |   |   | 65,000 |   |
| Hera Systems, Inc. Convertible Note*      |   |                | —    |   |              |   | 70,000  |                        |   |   | —            |   |   |                 | 70,000     |   |   |   | — |   |   |   | 703 |   |   |   | 151,795 |   |   |   | 70,000 |   |
| Hera Systems, Inc. Term Note*             |   |                | —    |   |              |   | 50,000  |                        |   |   | —            |   |   |                 | 50,000     |   |   |   | — |   |   |   | 1,101 |   |   |   | 108,425 |   |   |   | 50,000 |   |
| IntraOp Medical Corp. Series C Preferred* |   |                | 26,856,187 |   |              |   | — |                        |   |   | —            |   |   |                 | 26,856,187 |   |   |   | — |   |   |   | — |   |   |   | 16,018,641 |   |   |   | 26,299,938 |   |

----

|                                               |   | SHARES/PAR ACTIVITY |       |   |              |   |      |                        |   |   |               |   |   |                 |       |
|----------------------------------------------------|--------|---------------------|------------|--------|-------------------|--------|-----------|-----------------------------|--------|--------|--------------------|--------|--------|----------------------|------------|
| AFFILIATE/ CONTROLLED INVESTMENT*                  |   | BALANCE AT 12/31/16 |       |   | PURCHASES/ MERGER |   |      | SALES/ MATURITY/ EXPIRATION |   |   | BALANCE AT 6/30/17 |   |   | REALIZED GAIN (LOSS) |       |   | INTEREST |   |   | VALUE 6/30/17 |   |   | ACQUISITION COST |   |
| IntraOp Medical Corp. Convertible Note*            |   |                | 1,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 1,000,000  |   |   | $ | — |   |   | $ | 99,246 |   |   | $ | 1,000,000 |   |   | $ | 1,000,000 |   |
| IntraOp Medical Corp. Convertible Note*            |   |                | —    |   |              |   | 1,000,000 |                        |   |   | —            |   |   |                 | 1,000,000  |   |   |   | — |   |   |   | 12,740 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |
| IntraOp Medical Corp. Term Note*                   |   |                | 3,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 3,000,000  |   |   |   | — |   |   |   | 119,014 |   |   |   | 3,000,000 |   |   |   | 3,000,000 |   |
| IntraOp Medical Corp. Term Note*                   |   |                | —    |   |              |   | 2,000,000 |                        |   |   | —            |   |   |                 | 2,000,000  |   |   |   | — |   |   |   | 61,808 |   |   |   | 2,000,000 |   |   |   | 2,000,000 |   |
| Phunware Preferred Stock Series E                  |   |                | 3,257,328  |   |              |   | —   |                        |   |   | —            |   |   |                 | 3,257,328  |   |   |   | — |   |   |   | — |   |   |   | 6,807,490 |   |   |   | 9,999,997 |   |
| Pivotal Systems, Series A Preferred*               |   |                | 11,914,217 |   |              |   | —   |                        |   |   | —            |   |   |                 | 11,914,217 |   |   |   | — |   |   |   | — |   |   |   | 6,621,922 |   |   |   | 6,000,048 |   |
| Pivotal Systems, Series B Preferred*               |   |                | 13,065,236 |   |              |   | —   |                        |   |   | —            |   |   |                 | 13,065,236 |   |   |   | — |   |   |   | — |   |   |   | 7,261,658 |   |   |   | 6,321,482 |   |
| Pivotal Systems, Series C Preferred*               |   |                | 2,291,260  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,291,260  |   |   |   | — |   |   |   | — |   |   |   | 2,310,048 |   |   |   | 2,657,862 |   |
| Pivotal Systems, Series D Preferred*               |   |                | 6,237,978  |   |              |   | —   |                        |   |   | —            |   |   |                 | 6,237,978  |   |   |   | — |   |   |   | — |   |   |   | 4,174,455 |   |   |   | 3,975,801 |   |
| Pivotal Systems, Series D Warrants*                |   |                | 4,158,654  |   |              |   | —   |                        |   |   | —            |   |   |                 | 4,158,654  |   |   |   | — |   |   |   | — |   |   |   | 279,877 |   |   |   | — |   |
| Pivotal Systems, Common Stocks Warrants - Class B* |   |                | 18,180,475 |   |              |   | —   |                        |   |   | —            |   |   |                 | 18,180,475 |   |   |   | — |   |   |   | — |   |   |   | 5,529,228 |   |   |   | — |   |
| QMAT, Preferred Stock Series A*                    |   |                | 16,000,240 |   |              |   | —   |                        |   |   | —            |   |   |                 | 16,000,240 |   |   |   | — |   |   |   | — |   |   |   | 10,962,564 |   |   |   | 16,000,240 |   |
| QMAT, Preferred Stock Series B*                    |   |                | 2,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,000,000  |   |   |   | — |   |   |   | — |   |   |   | 2,000,000 |   |   |   | 2,000,000 |   |
| QMAT, Series A Warrant*                            |   |                | 2,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,000,000  |   |   |   | — |   |   |   | — |   |   |   | 394,600 |   |   |   | — |   |
| QMAT, Convertible Note*                            |   |                | —    |   |              |   | 1,000,000 |                        |   |   | —            |   |   |                 | 1,000,000  |   |   |   | — |   |   |   | 23,890 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |
| Revasum, Term Note*                                |   |                | —    |   |              |   | 1,000,000 |                        |   |   | —            |   |   |                 | 1,000,000  |   |   |   | — |   |   |   | 16,666 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |
| Revasum, Common Stock*                             |   |                | 10,000     |   |              |   | —   |                        |   |   | —            |   |   |                 | 10,000     |   |   |   | — |   |   |   | — |   |   |   | 11,538 |   |   |   | 1,000 |   |
| Revasum, Preferred Stock - Series Seed*            |   |                | 2,200,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,200,000  |   |   |   | — |   |   |   | — |   |   |   | 2,714,800 |   |   |   | 2,200,000 |   |
| Revasum, Preferred Stock Series A*                 |   |                | —    |   |              |   | 441,998   |                        |   |   | —            |   |   |                 | 441,998    |   |   |   | — |   |   |   | — |   |   |   | 1,474,594 |   |   |   | 1,999,997 |   |
| Silicon Genesis Corp., Common *                    |   |                | 921,892    |   |              |   | —   |                        |   |   | —            |   |   |                 | 921,892    |   |   |   | — |   |   |   | — |   |   |   | 15,488 |   |   |   | 169,045 |   |
| Silicon Genesis Corp., Common Warrant*             |   |                | 37,982     |   |              |   | —   |                        |   |   | —            |   |   |                 | 37,982     |   |   |   | — |   |   |   | — |   |   |   | 323 |   |   |   | 6,678 |   |
| Silicon Genesis Corp., Common Warrant*             |   |                | 5,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 5,000,000  |   |   |   | — |   |   |   | — |   |   |   | 10,000 |   |   |   | — |   |

----

|                                          |   | SHARES/PAR ACTIVITY |       |   |              |   |      |                        |   |   |               |   |   |                 |       |
|-----------------------------------------------|--------|---------------------|------------|--------|-------------------|--------|-----------|-----------------------------|--------|--------|--------------------|--------|--------|----------------------|------------|
| AFFILIATE/ CONTROLLED INVESTMENT*             |   | BALANCE AT 12/31/16 |       |   | PURCHASES/ MERGER |   |      | SALES/ MATURITY/ EXPIRATION |   |   | BALANCE AT 6/30/17 |   |   | REALIZED GAIN (LOSS) |       |   | INTEREST |   |   | VALUE 6/30/17 |   |   | ACQUISITION COST |   |
| Silicon Genesis Corp., Common Warrant*        |   |                | 3,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 3,000,000  |   |   | $ | — |   |   | $ | — |   |   | $ | 6,000 |   |   | $ | — |   |
| Silicon Genesis Corp., Series 1-C Preferred*  |   |                | 82,914     |   |              |   | —   |                        |   |   | —            |   |   |                 | 82,914     |   |   |   | — |   |   |   | — |   |   |   | 70,460 |   |   |   | 109,518 |   |
| Silicon Genesis Corp., Series 1-D Preferred*  |   |                | 850,830    |   |              |   | —   |                        |   |   | —            |   |   |                 | 850,830    |   |   |   | — |   |   |   | — |   |   |   | 194,500 |   |   |   | 431,901 |   |
| Silicon Genesis Corp., Series 1-E Preferred*  |   |                | 5,704,480  |   |              |   | —   |                        |   |   | —            |   |   |                 | 5,704,480  |   |   |   | — |   |   |   | — |   |   |   | 1,994,286 |   |   |   | 2,614,401 |   |
| Silicon Genesis Corp., Series 1-F Preferred*  |   |                | 912,453    |   |              |   | —   |                        |   |   | —            |   |   |                 | 912,453    |   |   |   | — |   |   |   | — |   |   |   | 444,365 |   |   |   | 509,785 |   |
| Silicon Genesis Corp., Series 1-G Preferred*  |   |                | 48,370,793 |   |              |   | —   |                        |   |   | —            |   |   |                 | 48,370,793 |   |   |   | — |   |   |   | — |   |   |   | 2,886,769 |   |   |   | 4,729,221 |   |
| Silicon Genesis Corp., Series 1-H Preferred*  |   |                | 837,942    |   |              |   | —   |                        |   |   | —            |   |   |                 | 837,942    |   |   |   | — |   |   |   | — |   |   |   | 229,847 |   |   |   | 963,494 |   |
| SVXR, Inc., Preferred Stock Series A          |   |                | —    |   |              |   | 2,013,491 |                        |   |   | —            |   |   |                 | 2,013,491  |   |   |   | — |   |   |   | 172 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | 2,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,000,000  |   |   |   | — |   |   |   | 110,208 |   |   |   | 267,400 |   |   |   | 2,000,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | 150,000    |   |              |   | —   |                        |   |   | —            |   |   |                 | 150,000    |   |   |   | — |   |   |   | 7,479 |   |   |   | 20,055 |   |   |   | 150,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | 500,000    |   |              |   | —   |                        |   |   | —            |   |   |                 | 500,000    |   |   |   | — |   |   |   | 25,781 |   |   |   | 66,850 |   |   |   | 500,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | 300,000    |   |              |   | —   |                        |   |   | —            |   |   |                 | 300,000    |   |   |   | — |   |   |   | 16,138 |   |   |   | 40,110 |   |   |   | 300,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | —    |   |              |   | 300,000   |                        |   |   | —            |   |   |                 | 300,000    |   |   |   | — |   |   |   | 4,917 |   |   |   | 40,110 |   |   |   | 300,000 |   |
| Telepathy Investors, Inc. Convertible Note*   |   |                | 500,000    |   |              |   | —   |                        |   |   | —            |   |   |                 | 500,000    |   |   |   | — |   |   |   | 24,794 |   |   |   | 66,850 |   |   |   | 500,000 |   |
| Telepathy Investors, Inc. Series A Preferred* |   |                | 15,238,000 |   |              |   | —   |                        |   |   | —            |   |   |                 | 15,238,000 |   |   |   | — |   |   |   | — |   |   |   | 882,280 |   |   |   | 3,999,999 |   |
| UCT Coatings, Inc., Common                    |   |                | 1,500,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 1,500,000  |   |   |   | — |   |   |   | — |   |   |   | 833,400 |   |   |   | 662,235 |   |
| UCT Coatings, Inc., Common Warrant            |   |                | 2,283      |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,283      |   |   |   | — |   |   |   | — |   |   |   | 3 |   |   |   | 67 |   |
| Vufine, Inc., Series A Preferred*             |   |                | 22,500,000 |   |              |   | —   |                        |   |   | —            |   |   |                 | 22,500,000 |   |   |   | — |   |   |   | — |   |   |   | 288,000 |   |   |   | 2,250,000 |   |
| Vufine, Inc., Convertible Note*               |   |                | —    |   |              |   | 500,000   |                        |   |   | —            |   |   |                 | 500,000    |   |   |   | — |   |   |   | 10,603 |   |   |   | 500,000 |   |   |   | 500,000 |   |
| Vufine, Inc., Common Stock*                   |   |                | 750,000    |   |              |   | —   |                        |   |   | —            |   |   |                 | 750,000    |   |   |   | — |   |   |   | — |   |   |   | 600 |   |   |   | 15,000 |   |
| Vufine, Inc., Convertible Note*               |   |                | 1,000,000  |   |              |   | —   |                        |   |   | —            |   |   |                 | 1,000,000  |   |   |   | — |   |   |   | 29,754 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |
| Wrightspeed, Inc. Convertible Note            |   |                | —    |   |              |   | 200,000   |                        |   |   | (200,000           | )      |   |                 | —    |   |   |   | — |   |   |   | 5,333 |   |   |   | — |   |   |   | — |   |
| Wrightspeed, Inc. Series C Preferred          |   |                | 2,267,659  |   |              |   | —   |                        |   |   | —            |   |   |                 | 2,267,659  |   |   |   | — |   |   |   | — |   |   |   | 5,819,040 |   |   |   | 6,864,023 |   |
| Wrightspeed, Inc. Series D Preferred          |   |                | 1,100,978  |   |              |   | —   |                        |   |   | —            |   |   |                 | 1,100,978  |   |   |   | — |   |   |   | — |   |   |   | 3,220,691 |   |   |   | 3,375,887 |   |

----

|                                        |   | SHARES/PAR ACTIVITY |    |   |              |   |    |                       |   |   |               |   |   |                 |    |
|---------------------------------------------|--------|---------------------|---------|--------|-------------------|--------|---------|----------------------------|--------|--------|--------------------|--------|--------|----------------------|---------|
| AFFILIATE/CONTROLLED INVESTMENT*            |   | BALANCE AT 12/31/16 |    |   | PURCHASES/ MERGER |   |    | SALES/MATURITY/ EXPIRATION |   |   | BALANCE AT 6/30/17 |   |   | REALIZED GAIN (LOSS) |    |   | INTEREST |   |   | VALUE 6/30/17 |   |   | ACQUISITION COST |   |
| Wrightspeed, Inc. Series E Preferred        |   |                | 450,814 |   |              |   | — |                       |   |   | —            |   |   |                 | 450,814 |   |   | $ | — |   |   | $ | - |   |   | $ | 1,375,433 |   |   | $ | 1,658,996 |   |
| Total Affiliates and Controlled Investments |   |                |    |   |              |   |    |                       |   |   |               |   |   |                 |    |   |   | $ | — |   |   | $ | 580,829 |   |   | $ | 101,949,836 |   |   | $ | 127,521,615 |   |
| Total Affiliates                            |   |                |    |   |              |   |    |                       |   |   |               |   |   |                 |    |   |   | $ | — |   |   | $ | 5,506 |   |   | $ | 19,056,057 |   |   | $ | 23,561,205 |   |
| Total Controlled Investments                |   |                |    |   |              |   |    |                       |   |   |               |   |   |                 |    |   |   | $ | — |   |   | $ | 575,323 |   |   | $ | 82,893,779 |   |   | $ | 103,960,410 |   |

| * | Controlled investment. |
|---|------------------------|

----

----

| • | our future operating results; |
|---------|-------------------------------|

| • | our business prospects and the prospects of our prospective portfolio companies; |
|---------|----------------------------------------------------------------------------------|

| • | the impact of investments that we expect to make; |
|---------|---------------------------------------------------|

| • | the impact of a protracted decline in the liquidity of the credit markets on our business; |
|---------|--------------------------------------------------------------------------------------------|

| • | our informal relationships with third parties; |
|---------|------------------------------------------------|

| • | the expected market for venture capital investments and our addressable market; |
|---------|---------------------------------------------------------------------------------|

| • | the dependence of our future success on the general economy and its impact on the industries in which we invest; |
|---------|------------------------------------------------------------------------------------------------------------------|

| • | our ability to access the equity market; |
|---------|------------------------------------------|

| • | the ability of our portfolio companies to achieve their objectives; |
|---------|---------------------------------------------------------------------|

| • | our expected financings and investments; |
|---------|------------------------------------------|

| • | our regulatory structure and tax status; |
|---------|------------------------------------------|

| • | our ability to operate as a business development company and a regulated investment company; |
|---------|----------------------------------------------------------------------------------------------|

| • | the adequacy of our cash resources and working capital; |
|---------|---------------------------------------------------------|

| • | the timing of cash flows, if any, from the operation of our portfolio companies; |
|---------|----------------------------------------------------------------------------------|

| • | the timing, form, and amount of any dividend distributions; |
|---------|-------------------------------------------------------------|

| • | impact of fluctuation of interest rates on our business; |
|---------|----------------------------------------------------------|

| • | valuation of any investments in portfolio companies particularly those having no liquid trading market; and |
|---------|-------------------------------------------------------------------------------------------------------------|

| • | our ability to recover unrealized losses. |
|---------|-------------------------------------------|

----

|                    | June 30, 2017 | December 31, 2016 |
|-------------------------|---------------|-------------------|
| Semiconductor Equipment | 23.1%         | 18.1%             |
| Medical Devices         | 16.5%         | 19.2%             |
| Advanced Materials      | 10.9%         | 9.1%              |
| Automotive              | 7.5%          | 7.0%              |
| Networking              | 6.6%          | 7.4%              |
| Cloud Computing         | 6.2%          | 5.7%              |
| Mobile Computing        | 4.9%          | 4.9%              |
| Consumer Electronics    | 4.4%          | 6.5%              |
| Intellectual Property   | 4.2%          | 4.1%              |
| Equipment Leasing       | 2.9%          | 2.7%              |
| Renewable Energy        | 2.7%          | 2.4%              |
| Semiconductor           | 1.1%          | 0.3%              |
| Aerospace               | 0.8%          | 0.4%              |
| Software                | 0.2%          | 0.2%              |
| Water Purification      | 0.0%          | 0.0%              |
| Advertising Technology  | —       | 6.9%              |
| Other Electronics       | —       | 0.9%              |
| Computer Storage        | —       | 0.1%              |
| Money Market Fund       | 3.0%          | 0.0%              |

----

| continued                             | June 30, 2017 | December 31, 2016 |
|---------------------------------------|---------------|-------------------|
| Exchange-Traded Funds                 |  — | 3.2%              |
| Other Assets in Excess of Liabilities | 5.0%          | 0.9%              |
| Net Assets                            | 100.0%        | 100.0%            |
| EARLY STAGE                                                                                              | MIDDLE STAGE                                                       | LATE STAGE*                                                                       |
|----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|-----------------------------------------------------------------------------------|
| Developing product or service for market, high level of research and  development, little or no revenue. | Established product, customers,  business model; limited revenues. | Appreciable revenue; may be break-evenor profitable; IPO or acquisitioncandidate. |
|                                                                                                     |                                                               |                                                                              |
|                                                                                                          |                                                                    |                                                                                   |

| * | Jawbone removed from chart. See note 12 in Consolidated Notes to Financial Statements. |
|---|----------------------------------------------------------------------------------------|

----

|                                                 |   | Three Months Ended June 30, 2017 |        |
|------------------------------------------------------|--------|----------------------------------|-------------|
| Realized gains                                       |   | $                                | 1,633,244   |   |
| Net change in unrealized depreciation on investments |   |                             | (10,039,664 | ) |
| Net realized and unrealized loss on investments      |   | $                                | (8,406,420  | ) |
|                                                   |   | As of June 30, 2017 |        |
|--------------------------------------------------------|--------|---------------------|-------------|
| Gross unrealized appreciation on portfolio investments |   | $                   | 12,956,208  |   |
| Gross unrealized depreciation on portfolio investments |   |                | (48,527,789 | ) |
| Net unrealized depreciation on portfolio investments   |   | $                   | (35,571,581 | ) |

----

|                                                 |   | Three Months Ended June 30, 2016 |       |
|------------------------------------------------------|--------|----------------------------------|------------|
| Realized gains                                       |   | $                                | 4,212,691  |   |
| Net change in unrealized depreciation on investments |   |                             | (4,328,627 | ) |
| Net realized and unrealized loss on investments      |   | $                                | (115,936   | ) |
|                                                   |   | As of June 30, 2016 |        |
|--------------------------------------------------------|--------|---------------------|-------------|
| Gross unrealized appreciation on portfolio investments |   | $                   | 12,283,155  |   |
| Gross unrealized depreciation on portfolio investments |   |                | (39,498,300 | ) |
| Net unrealized depreciation on portfolio investments   |   | $                   | (27,215,145 | ) |

----

|                                                 |   | Six Months Ended June 30, 2017 |       |
|------------------------------------------------------|--------|--------------------------------|------------|
| Realized gains                                       |   | $                              | 560,792    |   |
| Net change in unrealized depreciation on investments |   |                           | (8,315,281 | ) |
| Net realized and unrealized losses on investments    |   | $                              | (7,754,489 | ) |
|                                                   |   | As of June 30, 2017 |        |
|--------------------------------------------------------|--------|---------------------|-------------|
| Gross unrealized appreciation on portfolio investments |   | $                   | 12,956,208  |   |
| Gross unrealized depreciation on portfolio investments |   |                | (48,527,789 | ) |
| Net unrealized depreciation on portfolio investments   |   | $                   | (35,571,581 | ) |

----

|                                                       |   | Six Months Ended June 30, 2016 |        |
|------------------------------------------------------------|--------|--------------------------------|-------------|
| Realized gains                                             |   | $                              | 7,527,534   |   |
| Net change in unrealized depreciation on investments  |   |                           | (14,617,557 | ) |
| Net realized and unrealized losses on investments          |   | $                              | (7,090,023  | ) |
|                                                   |   | As of June 30, 2016 |        |
|--------------------------------------------------------|--------|---------------------|-------------|
| Gross unrealized appreciation on portfolio investments |   | $                   | 12,283,155  |   |
| Gross unrealized depreciation on portfolio investments |   |                | (39,498,300 | ) |
| Net unrealized depreciation on portfolio investments   |   | $                   | (27,215,145 | ) |

----

----

----

----

| ITEM 4. | CONTROLS AND PROCEDURES. |   |
|---------|--------------------------|--------|

----

| (a) Evaluation of Disclosure Controls and Procedures      | As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. |
|----------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (b) Changes in Internal Control Over Financial Reporting  | There have been no changes in our internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act, that occurred during the fiscal quarter ended June 30, 2017, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

----

----

----

----

----

----

----

----

----

----

| EXHIBIT NUMBER | DESCRIPTION                                                                                                                                                                                                  |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1           | Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                   |
| 31.2           | Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                   |
| 32.            | Chief Executive Officer and Chief Financial Officer Certification Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |

----

|                        |   | FIRSTHAND TECHNOLOGY VALUE FUND, INC. |
|-----------------------------|--------|---------------------------------------|
|                        |   |                                  |
|                        |   |                                  |
| Dated: August 9, 2017  | By:    |                                       |
|                        |   | Kevin Landis                          |
|                        |   | Chief Executive Officer               |
|                        |   |                                  |
|                        |   |                                  |
| Dated: August 9, 2017       | By:    |                                       |
|                        |   | Omar Billawala                        |
|                        |   | Chief Financial Officer               |
| EXHIBIT NUMBER | DESCRIPTION                                                                                                                                                                                                  |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1           | Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                   |
| 31.2           | Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                   |
| 32.            | Chief Executive Officer and Chief Financial Officer Certification Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |